Literature DB >> 25643990

Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery.

Yixuan Dong1, Pin Dong2, Di Huang2, Liling Mei2, Yaowen Xia2, Zhouhua Wang2, Xin Pan3, Ge Li4, Chuanbin Wu5.   

Abstract

The unique structure and protective mechanisms of the eye result in low bioavailability of ocular drugs. Using a mucoadhesive material is an efficient solution to improve ocular drug therapeutic efficacy. This study was designed to prepare a liposomal formulation coated by a novel adhesive excipient, silk fibroin (SF), for topical ocular drug delivery. The regenerated silk fibroins (SFs) with different dissolving time were coated onto the ibuprofen-loaded liposomes. The morphology, drug encapsulation efficiency, in vitro release and in vitro corneal permeation of SF-coated liposomes (SLs) were investigated in comparison with the conventional liposome. Cellular adhesion and cytotoxicity assay of SF and SLs were tested using human corneal epithelial cells (HCEC). SLs showed sustained drug release and in vitro corneal permeation of ibuprofen as compared to drug solution and conventional liposome. The cellular fluorescence appeared after 7 min of exposure to SF, and the intensity increased sustainedly up to 12h with no detectable cytotoxicity. Higher fluorescence intensity of Nile red in SLs was observed in a short period of 15 min showing a rapid uptake. These favorable properties make SF-coated liposome be a promising ocular drug delivery system.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell culture; Coating; Liposomes; Ocular drug delivery; Silk fibroin; Sustained release

Mesh:

Substances:

Year:  2015        PMID: 25643990     DOI: 10.1016/j.ejpb.2015.01.018

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  14 in total

Review 1.  Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.

Authors:  I Bravo-Osuna; V Andrés-Guerrero; P Pastoriza Abal; I T Molina-Martínez; R Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  Antioxidative NAC-Loaded Silk Nanoparticles with Opening Mucosal Tight Junctions for Nasal Drug Delivery: An In Vitro and In Vivo Study.

Authors:  Tze-Wen Chung; Ting-Ya Wu; Zheng-Yu Siah; Der-Zen Liu
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

Review 3.  Challenges in delivering therapeutic peptides and proteins: A silk-based solution.

Authors:  Junqi Wu; Jugal Kishore Sahoo; Yamin Li; Qiaobing Xu; David L Kaplan
Journal:  J Control Release       Date:  2022-02-11       Impact factor: 11.467

Review 4.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

Review 5.  A Review of the Emerging Role of Silk for the Treatment of the Eye.

Authors:  Simon H Tran; Clive G Wilson; F Philipp Seib
Journal:  Pharm Res       Date:  2018-11-05       Impact factor: 4.200

Review 6.  Tissue Regeneration: A Silk Road.

Authors:  Dave Jao; Xiaoyang Mou; Xiao Hu
Journal:  J Funct Biomater       Date:  2016-08-05

Review 7.  The Potential of Silk and Silk-Like Proteins as Natural Mucoadhesive Biopolymers for Controlled Drug Delivery.

Authors:  Amanda E Brooks
Journal:  Front Chem       Date:  2015-11-26       Impact factor: 5.221

8.  Supercritical carbon dioxide-developed silk fibroin nanoplatform for smart colon cancer therapy.

Authors:  Maobin Xie; Dejun Fan; Yi Li; Xiaowen He; Xiaoming Chen; Yufeng Chen; Jixiang Zhu; Guibin Xu; Xiaojian Wu; Ping Lan
Journal:  Int J Nanomedicine       Date:  2017-10-20

Review 9.  Silk Fibroin as a Functional Biomaterial for Drug and Gene Delivery.

Authors:  Mhd Anas Tomeh; Roja Hadianamrei; Xiubo Zhao
Journal:  Pharmaceutics       Date:  2019-09-26       Impact factor: 6.321

Review 10.  Fibroin nanoparticles: a promising drug delivery system.

Authors:  Duy Toan Pham; Waree Tiyaboonchai
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.